The FDA will require vaccine makers to run fresh clinical trials before offering shots to younger and healthier individuals.
US limits Covid-19 boosters to over-65s or those at high risk
RELATED ARTICLES
The FDA will require vaccine makers to run fresh clinical trials before offering shots to younger and healthier individuals.
